{"nct_id":"NCT05996445","title":"A Study of XmAb®662 as Monotherapy or in Combination With Pembrolizumab in Advanced Solid Tumors","status":"TERMINATED","status_verified_date":"2024-08","start_date":"2023-07-28","start_date_type":"ACTUAL","primary_completion_date":"2024-05-21","primary_completion_date_type":"ACTUAL","completion_date":"2024-05-21","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["XNCR"]}